Treatment of intractable autoimmune diseases in MRL/lpr mice using a new strategy for allogeneic bone marrow transplantation

Blood

Volumn 95, Issue 5, 2000, Pages 1862-1868

  Kushida, Taketoshi ^a   Inaba, Muneo ^a   Takeuchi, Kenji ^a   Sugiura, Kikuya ^a   Ogawa, Ryokei ^a   Ikehara, Susumu ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ARTICLE; AUTOIMMUNE DISEASE; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; MOUSE; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; SURVIVAL; TECHNIQUE; TREATMENT OUTCOME;

EID: 0034161317     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.5.1862.005k27_1862_1868     Document Type: Article

References (49)

1. Theofilopoulos AR, Dixon FJ. Murine models of systemic lupus erythematosus. Adv Immunol. 1985;37:269.
2. Ikehara S, Good RA, Nakamura T, et al. Rationale for bone marrow transplantation in the treatment of autoimmune disease. Proc Natl Acad Sci U S A. 1985;82:2483.
3. Ikehara S, Ohtsuki H, Good RA, et al. Prevention of type I diabetes in nonobese diabetic mice by allogeneic bone marrow transplantation. Proc Natl Acad Sci U S A 1985;82:7743.
4. Oyaizu N, Yasumizu R, Inaba-Miyama M, et al. (NZW x BXSB)F1 mouse, a new model of idiopathic thrombocytopenic purpura. J Exp Med. 1988;167:2017.
5. Nakagawa T, Nagata N, Hosaka N, Ogawa R, Nakamura K, Ikehara S. Prevention of autoimmune inflammatory polyarthritis in male New Zealand black/KN mice by transplantation of bone marrow cells plus bone (stromal cells). Arthritis Rheum. 1993;36:263.
6. Nishimura M, Toki J, Sugiura K, et al. Focal segmental glomerular sclerosis, a type of intractable chronic glomerulonephritis, is a stem cell disorders. J Exp Med. 1994;179:1053.
7. Soe T, Ishida H, Inaba M, et al. Bone marrow transplantation as a strategy for treatment of non-insulin-dependent diabetes mellitus in KK-Ay mice. J Exp Med. 1992;176:1233.
8. Ikehara S, Yasumizu R, Inaba M, et al. Long-term observations of autoimmune-prone mice treated for autoimmune disease by allogeneic bone marrow transplantation. Proc Natl Acad Sci U S A. 1989;86:3306.
9. Ikehara S. Bone marrow transplantation for autoimmune diseases. Acta Haematol. 1998;99:116.
10. Ikehara S. Autoimmune diseases as stem cell disorders: normal stem cell transplant for their treatment (Review). Int J Mol Med. 1998;1:5.
11. Ikehara S, Kawamura M, Takao F, et al. Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells. Proc Natl Acad Sci U S A. 1990;87:8341.
12. Kawamura M, Hisha H, Li Y, Fukuhara S, Ikehara S. Distinct qualitative differences stem cells in vivo and in vitro. Stem Cells. 1997;15:56.
13. Baldwin JL, Strob R, Thomas ED, Mannik M. Bone marrow transplantation in patients with gold-induced marrow aplasia. Arthritis Rheum. 1977;20:1043.
14. Jacobs P, Vincent MD, Martell RW. Prolonged remission of severe refractory rheumatoid arthritis following allogeneic bone marrow transplantation for drug-induced aplastic anemia. Bone Marrow Transplant. 1986;1:237.
15. Lowenthal RM, Cohen ML, Atkinson K, Biggs JC. Apparent cure of rheumatoid arthritis by bone marrow transplantation. J Rheumatol. 1993;20:137.
16. Eedy DJ, Burrows D, Bridges JM, Jones FF. Clearance of severe psoriasis after allogeneic bone marrow transplantation. Br Med J. 1990;300:908.
17. Liu Yin JA, Jowitt SN. Resolution of immune-mediated diseases following allogeneic bone marrow transplantation for leukaemia. Bone Marrow Transplant. 1992;9:31.
18. Marmont AM. Immune ablation followed by allogeneic or autologous bone marrow transplantation: A new treatment for severe autoimmune diseases? Stem Cells. 1994;12:125.
19. Sullivan KM, Furst DE, eds. Role of Hematopoietic Stem Cell Transplantation for Autoimmune Diseases. Seattle, WA: Fred Hutchinson Cancer Research Center, J Rheumatol vol 24. (Suppl 48), 1997, p 1.
20. Nelson JL, Torrez R, Louie FM, Choe OS, Storb R, Sullivan KM. Pre-existing autoimmune diseases in patients with longterm survival after allogeneic bone marrow transplantation. J Rheumatol. 1997;24:23.
21. Grau JM, Casademont J, Monforte R, et al. Myasthenia gravis after allogeneic bone marrow transplantation: report of a new case and pathogenetic considerations. Bone Marrow Transplant. 1990;5:435.
22. Melms A, Faul C, Sommer N, Wietholter H, Muller CA, Ehninger G. Myasthenia gravis after BMT: identification of patients at risk? Bone Marrow Transplant. 1992;9:78.
23. Wyatt DT, Lum L, Casper J, Hunter J, Camitta B. Autoimmune thyroiditis after bone marrow transplantation. Bone Marrow Transplant. 1990;5:357.
24. Aldouri MA, Ruggier R, Epstein O, Prentice HG. Adoptive transfer of hyperthyroidism and autoimmune thyroiditis following allogeneic bone marrow transplantation for chronic myeloid leukaemia. Br J Haematol. 1990;74:118.
25. Hagopian W, Lernmark A. Autoimmune diabetes mellitus. In: Rose RR, Mackay IR, eds. The Autoimmune Diseases II. San Diego, CA: Academic Press; 1992:235.
26. Lampeter EF, Homberg M, Quabeck K, et al. Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet. 1993;341:1243.
27. Vialettes B, Maraninchi D, San Marco MP, et al. Autoimmune polyendocrine failure-type I (insulin-dependent) diabetes mellitus and hypothyroidism-after allogeneic bone marrow transplantation in a patient with lymphoblastic leukaemia. Diabetologia. 1993;36:541.
28. Lampeter EB. Discussion remark to session 24: BMT in autoimmune diseases. Exp Hematol. 1993;21:1153.
29. Holland FJ, McConnon JK, Volpe R, Saunders EF. Concordant Graves' disease after bone marrow transplantation: implication for pathogenesis. J Clin Endocrinol Metab. 1991;72:837.
30. Marmont AM. Stem cell transplantation (or severe autoimmune diseases: progress and problems. Haematologica. 1998;83:733.
31. Burt RK. BMT for severe autoimmune diseases: An idea whose time has come. Oncology. 1997;11:1001.
32. Tyndall A, Black C, Finke J, et al. Treatment of systemic sclerosis with autologous haematopoietic stem cell transplantation. Lancet. 1997;349:254.
33. Euler HH, Marmont AM, Bacigalupo A, et al. Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation. Blood. 1996;88:3621.
34. Ishida T, Inaba M, Hisha H, et al. Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation. J Immunol. 1994;152:3119.
35. Hisha H, Nishino T, Kawamura M, Adachi S, Ikehara S. Successful bone marrow transplantation by bone grafts in chimeric-resistant combination. Exp Hematol. 1994;23:347.
36. Hashimoto F, Sugiura K, Inoue K, Ikehara S. Major histocompatibility complex restriction between hematopoietic stem cells and stromal cells in vivo. Blood. 1997;89:49.
37. Takeuchi K, Inaba M, Miyashima S, Ogawa R, Ikehara S. A new strategy for treatment of autoimmune diseases in chimeric resistant MRL/lpr mice. Blood. 1998;91:4616.
38. Zhang Y, Yasumizu R, Sugiura K, et al. Fate of allogeneic or syngeneic cells in intravenous or portal vein injection: possible explanation by portal vein injection. Eur J Immunol. 1994;24:1558.
39. Sugiura K, Kato K, Hashimoto F, et al. Induction of donor-specific T cell anergy by portalvenous injection of allogeneic cells. Immunobiol. 1997;197:460.
40. Morita H, Sugiura K, Inaba M, et al. A strategy for organ allografts without using immunosuppressants or irradiation. Proc Natl Acad Sci U S A. 1998;95:6947.
41. Miyashima S, Nagata N, Nakagawa T, et al. Prevention of lpr-graft-versus-host disease and transfer of autoimmune diseases in normal C57BL/6 mice by transplantation of bone marrow cells plus bone (stromal cells) from MRL/lpr mice. J Immunol. 1996;156:79-84.
42. Martin PJ. Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans. J Exp Med. 1993;178:703.
43. Wofsy D, Ledbetter JA, Hendler PL, Seaman WE. Treatment of murine lupus with monoclonal anti-T cell antibody. J Immunol. 1985;134:852.
44. + T cells to lymphoproliferation and autoantibody production in MRL-lpr/lpr mice. J Exp Med. 1988;167:1713.
45. Van Bekkum DW, Bohre EPM, Houben PFJ, Knaan-Shanzer S. Regression of adjuvant-induced arthritis in rats following bone marrow transplantation. Proc Natl Acad Sci U S A. 1989;86:10,090.
46. Knaan-Shanzer S, Houben P, Kinwel-Bohre EPM, Van Bekkum DW. Remission induction of adjuvant arthritis in rats by total body irradiation and autologous bone marrow transplantation. Bone Marrow Transplant. 1991;8:333.
47. Karussis DM, Slavin S, Lehman D, Mizrachi-Kol R, Abramsky, O, Ben-Nun A. Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immuno-suppression followed by syngeneic bone marrow transplantation. J Immunol. 1992;48:1693.
48. Van Gelder M, Kinwel-Bohre EPM, Van Bekkum DW. Treatment of experimental allergic encephalomyetitis with bone marrow transplantation. Exp Hematol. 1993;21:1155.
49. Burt RK, Padilla J, Begolka WS, Dal Canto MC, Miller SD. Effect of disease stage on clinical outcome after syngeneic bone marrow transplantation for relapsing experimental autoimmune encephalomyelitis. Blood. 1998;91:2609.